Skip to content
10-Q

Quarterly Report

THESEUS PHARMACEUTICALS, INC.

0001745020-23-000050

← back to feed
Filed
Aug 10, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 4, 2023 43.6M sh
Shares Diluted Q2 2023 · Jun 30, 2023 43.74M sh
Shares Diluted Q2 2023 · Jun 30, 2023 43.06M sh
Shares Diluted Q2 2023 · Jun 30, 2022 38.42M sh
Shares Diluted Q2 2023 · Jun 30, 2022 38.33M sh
Capex Q2 2023 · Jun 30, 2023 $11K
Capex Q2 2023 · Jun 30, 2022 $381K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$28.67M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$15.78M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $47.47M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $94.61M
Cash And Equivalents Q2 2023 · Jun 30, 2022 $135.09M
Stockholders Equity Q2 2023 · Jun 30, 2023 $234.08M
Stockholders Equity Q2 2023 · Mar 31, 2023 $245.49M
Stockholders Equity Q2 2023 · Dec 31, 2022 $207.62M
Stockholders Equity Q2 2023 · Jun 30, 2022 $229M
Stockholders Equity Q2 2023 · Mar 31, 2022 $237.85M
Stockholders Equity Q2 2023 · Dec 31, 2021 $246.43M
Current Liabilities Q2 2023 · Jun 30, 2023 $7.68M
Current Liabilities Q2 2023 · Dec 31, 2022 $11.13M
Total Liabilities Q2 2023 · Jun 30, 2023 $10.99M
Total Liabilities Q2 2023 · Dec 31, 2022 $14.83M
Current Assets Q2 2023 · Jun 30, 2023 $213.75M
Current Assets Q2 2023 · Dec 31, 2022 $202.12M
Total Assets Q2 2023 · Jun 30, 2023 $245.07M
Total Assets Q2 2023 · Dec 31, 2022 $222.45M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.34
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.68
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.30
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.58
Eps Basic Q2 2023 · Jun 30, 2023 −$0.34
Eps Basic Q2 2023 · Jun 30, 2023 −$0.68
Eps Basic Q2 2023 · Jun 30, 2022 −$0.30
Eps Basic Q2 2023 · Jun 30, 2022 −$0.58
Sga Expense Q2 2023 · Jun 30, 2023 $4.67M
Sga Expense Q2 2023 · Jun 30, 2023 $9.32M
Sga Expense Q2 2023 · Jun 30, 2022 $4.74M
Sga Expense Q2 2023 · Jun 30, 2022 $8.77M
Rd Expense Q2 2023 · Jun 30, 2023 $12.92M
Rd Expense Q2 2023 · Jun 30, 2023 $25.32M
Rd Expense Q2 2023 · Jun 30, 2022 $7.34M
Rd Expense Q2 2023 · Jun 30, 2022 $13.89M
Net Income Q2 2023 · Jun 30, 2023 −$14.81M
Net Income Q2 2023 · Jun 30, 2023 −$29.39M
Net Income Q2 2023 · Mar 31, 2023 −$14.59M
Net Income Q2 2023 · Jun 30, 2022 −$11.65M
Net Income Q2 2023 · Jun 30, 2022 −$22.15M
Net Income Q2 2023 · Mar 31, 2022 −$10.5M
Operating Income Q2 2023 · Jun 30, 2023 −$17.59M
Operating Income Q2 2023 · Jun 30, 2023 −$34.64M
Operating Income Q2 2023 · Jun 30, 2022 −$12.08M
Operating Income Q2 2023 · Jun 30, 2022 −$22.66M